Isobe Shinsuke, Ohashi Naro, Katahashi Naoko, Ishigaki Sayaka, Tsuji Naoko, Tsuji Takayuki, Kato Akihiko, Fujigaki Yoshihide, Shimizu Akira, Yasuda Hideo
Internal Medicine 1, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Blood Purification Unit, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
CEN Case Rep. 2017 Nov;6(2):206-209. doi: 10.1007/s13730-017-0276-z. Epub 2017 Sep 22.
Cutaneous and systemic plasmacytosis (CSP) is a rare lymphoproliferative disorder that mainly affects middle-aged Asian individuals. Although Castleman disease is often complicated with various renal involvements, glomerulonephritis associated with CSP, which is considered as a variant of Castleman disease, is rare. This report presents the case of a 41-year-old Japanese man with nephrotic syndrome associated with CSP. Renal biopsy findings showed focal segmental glomerulosclerosis (FSGS) and diffusely mild segmental mesangial proliferation. Plasma cell infiltration in the interstitium was not observed. Electron microscopic findings showed diffuse foot process effacement, localized involvement of subendothelial space widening with amorphous materials, and endothelial cell swelling. Lymph node biopsy findings denied Castleman disease. His skin regions and proteinuria were successfully treated with prednisolone and cyclosporine. The causal relationship between CSP and FSGS is unknown. However, increased serum levels of IL-6 and VEGF and decreased VEGF expression in the podocyte may contribute to renal lesions in patients with CSP. To our best knowledge, this is the first case of a patient with FSGS associated with CSP.
皮肤及系统性浆细胞增多症(CSP)是一种罕见的淋巴增殖性疾病,主要影响中年亚洲人。虽然Castleman病常伴有各种肾脏受累情况,但与CSP相关的肾小球肾炎(被认为是Castleman病的一种变体)却很罕见。本报告介绍了一例患有与CSP相关的肾病综合征的41岁日本男性病例。肾活检结果显示局灶节段性肾小球硬化(FSGS)和弥漫性轻度节段性系膜增生。未观察到间质中的浆细胞浸润。电子显微镜检查结果显示弥漫性足突消失、内皮下间隙局限性增宽伴无定形物质以及内皮细胞肿胀。淋巴结活检结果排除了Castleman病。他的皮肤病变区域和蛋白尿通过泼尼松龙和环孢素成功得到治疗。CSP与FSGS之间的因果关系尚不清楚。然而,血清IL - 6和VEGF水平升高以及足细胞中VEGF表达降低可能导致CSP患者出现肾脏病变。据我们所知,这是第一例与CSP相关的FSGS患者。